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Toward a Better Understanding of...

The Role of NF-kB p65 in Subarachnoid
Hemorrhage Induced Secondary Brain Injury
Molly Lawrence
Mentor: Itender Singh
Subarachnoid hemorrhage (SAH), primarily caused by rupture of a cerebral aneurysm,
refers to the extravasation of blood into subarachnoid space between the pial and
arachnoid membranes. With high mortality and morbidity rates, the initial hemorrhage
itself is often fatal, but the primary cause of poor outcomes is through the secondary
brain injuries that develop in the days following SAH. There are two separate categories
of these damages, distinguished as early brain injury (EBI) and delayed cerebral ischemia
(DCI). Occurring 1-3 days following SAH, EBI presents as neuroinflammation, cerebral
edema, and blood-brain barrier (BBB) disruption. DCI, the more common and
devastating category, describes the slower onset damages, 4-12 days post-SAH, including
microcirculatory deficits and large artery vasospasm. There is strong evidence that
vascular deficits are the main cause of these secondary brain injuries, with blood-brain
barrier (BBB) disruption leading to EBI and large artery vasopasm leading to DCI. Several
previous studies have shown that a strong genetic risk factor for these poor outcomes
after SAH is the presence of apolipoprotein E4 allele. The APOE4 linked pathway
involves cyclophilin A (CypA), a cell signaling molecule that causes inflammation
through activation of transcription factor nuclear factor kappa-light-chain-enhancer
of activated B cells (NF-kB) p65 and resulting induction of matrix metalloproteinase-9
(MMP9) and BBB disruption. However, the role of CypA in secondary brain injury has
not yet been clearly established. Early findings showing high levels of CypA in rodents
after SAH, we hypothesize that the CypA- NF-kB p65 -MMP9 pathway plays a critical
role in SAH-induced EBI and DCI.
With CypA inhibition and MMP9 knockouts displaying reduced post-SAH BBB
leakage and vascular deficits, our objective for this study was to confirm the role of
NF-kB p65 in this pathway. To assess this, wild-type C57BL6 mice were administered
a pharmacological inhibitor of NF-kb p65, ammonium pyrrolidinedithiocarbamate
(PDTC), via intraperitoneal injection the day of SAH surgery and daily for three
days following (Day 0 - Day 3). Cognitive and motor skills of the mice were assessed
Day 0 - Day 3 via neuroscoring and rotarod along with their littermate controls (also
administered SAH). On Day 3, the mice were sacrificed by India ink-gelatin perfusion,
which fixes and stains the brain vessels to allow imaging and measurement of the middle
cerebral artery to assess vasospasm. The mice with p65 inhibition showed significantly
less cognitive impairment and vasospasm than their littermate controls, corroborating
our hypothesis of the role of the transcription factor in the induction of post-SAH
deficits and suggesting p65 to be a promising potential therapeutic target for SAH.
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